Latest news with #DCCPLC
Irish Independent
22-07-2025
- Business
- Irish Independent
DCC seeks fast-track of process to return cash to investors
DCC PLC is the parent of DCC Energy, which specialises in the sale, marketing and distribution of clean energy solutions, and of DCC Technology, a specialist distribution partner for global technology and appliance brands and customers. It was also the parent of DCC Healthcare, a provider of high-quality medical devices and other healthcare products, and also partners with brands to create and manufacture health and beauty products, until it decided to sell that division. A large proportion of the income of DCC group, which is London-listed and Dublin-headquartered, is generated in the UK. In November last, DCC announced it would focus on the energy division and began preparations for the sale of the healthcare division, CEO Donal Murphy said in an affidavit. In April, an agreement was entered into to sell the division and in May it announced it intended to return £800m (€923m) to shareholders, he said, through a reduction in share capital. Mr Murphy said the capital reduction is a step in the larger process of focusing the business of the company on the energy sector and deploying the proceeds of the sale of the healthcare division for the benefit of the shareholders. He was commenting as the company sought to have the legal process entered in the fast-track Commercial Court. It is envisaged the transaction will be completed by September. Lyndon MacCann SC, who made the application to Mr Justice Mark Sanfey yesterday, said he was looking for a date for a hearing of the matter during the court vacation in August. The judge said while it was not normal to deal with such applications in August, he understood the urgency of the matter. He said he would be writing up judgments in August and he would hear it during that week. In April, DCC announced the sale of the healthcare arm to HealthCo Investment – a subsidiary of European investment firm Investindustrial Advisors – in a deal valuing the division at £1.05bn. The sale price was lower than analysts had anticipated, reflecting market volatility at the time, in the wake of the shock unleashed by US president Donald Trump's so called 'Liberation Day' tariffs announcement that month.
Yahoo
14-05-2025
- Business
- Yahoo
DCC PLC (DCCPF) (FY 2025) Earnings Call Highlights: Strategic Energy Focus and Shareholder ...
Release Date: May 13, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. DCC PLC (DCCPF) announced a strategic focus on its energy business, which is expected to drive significant growth and shareholder value. The company reported strong financial performance in its energy division, with an 8.5% constant currency operating profit growth. DCC PLC (DCCPF) plans a material capital return to shareholders following the sale of DCC Healthcare for GBP 1.05 billion. The energy business is characterized by high returns on capital and excellent cash generation, supporting its growth ambitions. DCC PLC (DCCPF) has a strong balance sheet and cash generative nature, providing significant capital for growth and shareholder returns. DCC Technology division faced challenges, with a 14% decline in profits on a constant currency basis due to weak demand in Europe. The company experienced a 4.5% decline in revenue from continuing activities, driven by reduced wholesale energy commodity costs. DCC PLC (DCCPF) is undergoing a strategic review of its technology division, indicating potential uncertainty or restructuring. The Infotech segment within DCC Technology has been operating in a challenging market, leading to exits from certain regions. The company anticipates a modest working capital outflow in FY26, following an exceptional performance in the prior year. Warning! GuruFocus has detected 3 Warning Sign with DCCPF. Q: Can you provide more details on the impressive 49% organic revenue growth in the energy services segment? A: Don Murphy, CEO: The strong growth in our energy services segment is primarily driven by our operations in France, where we have established a nationwide platform through the acquisition of seven businesses. This has allowed us to achieve high levels of organic growth, and we have a robust pipeline for the current year. The energy services business is delivering high operating margins and is a very attractive growth area for us. Q: There seems to be a dip in the pence per liter margin for energy products this year. Can you explain the reasons behind this and your outlook for the future? A: Kevin Lucy, CFO: The dip in margin per liter is primarily due to mix changes. Last year, we had an exceptionally strong performance due to dislocation in the natural gas markets, which drove demand for liquid gas. This year, the margin per liter has normalized, but we are still well above the levels seen in 2021 and 2022. We expect to continue growing our margins over time. Q: Regarding the technology division, are you seeing it as two distinct parts, given the varying performance across segments? A: Don Murphy, CEO: Yes, the technology division can be viewed in two parts. Infotech, which has been challenging, involves high-volume, low-margin activities. In contrast, Protech and LifeTech are high-quality businesses. We are focused on delivering operational integration in North America and expect technology to return to growth this year. Q: What assumptions are you making for energy products volumes and margins in your outlook? A: Kevin Lucy, CFO: Our outlook for energy products volumes is based on relatively mature markets in Europe and North America. We expect modest growth driven by market share gains and demand for liquid gas, particularly from commercial and industrial customers. For margins, we anticipate a 1-3% improvement per liter, supported by higher-margin products like biofuels and ongoing efficiency improvements. Q: Can you provide more details on the expected capital return to shareholders following the sale of DCC Healthcare? A: Kevin Lucy, CFO: We plan to return up to 800 million to shareholders, with 600 million following the completion of the DCC Healthcare sale. The form of the return is yet to be decided, but it will likely involve a material reduction in the share count. The remaining 100 million will be returned after receiving the unconditional deferred consideration. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
